The Lancet HIV in conversation with
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
Podcasting since 2015 • 82 episodes
The Lancet HIV in conversation with
Latest Episodes
Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda
Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s succes...
•
25:16
Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV
In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results.Read the full article...
•
16:23
Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Gra...
•
13:50
Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality
Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic? Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute ...
•
24:00
Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes
Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression.
•
21:28